Article
Clinical Potential of Oligonucleotide Therapeutics against Pancreatic Cancer
2019-05-20
Abstract excerpt
Although there is a several array of diagnostic and therapeutic choices for pancreatic cancer in recent years, a crucial medical approach for the refractory disease is still needed. Oligonucleotide therapeutics, such as those based on antisense RNAs, RNA interference, aptamers and decoys, are promising agents against pancreatic cancer because they identify a specific nucleotide sequence or protein and interfere wi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3388da52-8c66-52d0-b7b7-d88cb3dc6c1a
- DOI
- 10.20944/preprints201905.0239.v1